HOME >> BIOLOGY >> NEWS
Discovery could improve anemia treatment in patients

NOTE: This release has been updated since its original posting.

Patients with chronic inflammatory disorders, including infections, inflammatory bowel disease, arthritis and cancer, commonly become anemic. The anemia can make them sicker, is sometimes severe enough to require a blood transfusion, and responds only partially to current treatments. Researchers at Children's Hospital Boston, Harvard Medical School, and the European Molecular Biology Laboratory have unraveled the complicated biology behind this type of anemia and propose new targets for drug development. They report their findings in the April 18 edition of Nature Genetics.

A Children's Hospital team led by Cindy Roy in CHB's Division of Hematology/Oncology previously showed that anemia of chronic disease results from over-activation of hepcidin, a hormone involved in controlling iron in the body. Hepcidin is triggered by inflammation and may also help fight infection, both by directly inactivating pathogens and by reducing the amount of iron circulating in the blood. This "iron withholding" deprives infectious pathogens of a nutrient they need to proliferate, but it also reduces the iron available to developing red blood cells. As a result, patients become anemic.

Now, Roy and colleagues have identified a key regulator of hepcidin, a protein called HFE. The researchers showed that genetically engineered mice with deficiencies in HFE maintained elevated levels of iron in the blood during inflammation. "What we've shown is that unless you have the HFE protein, you can't mount this iron-withholding response," says Roy, who holds a doctorate in cell biology. "By turning off HFE, you turn off hepcidin and it's ability to respond to inflammation."

Anemia of chronic disease is often treated with iron or erythropoietin, a growth hormone for red blood cells, but neither is fully effective because hepcidin blocks the necessary iron from getting to the red cells. "An important n
'"/>

Contact: Mary-Ellen Shay
mary.shay@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
18-Apr-2004


Page: 1 2 3

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could lead to better treatment for cryptosporidum infections
9. Discovery of brain disorder gene paves way for genetic test
10. Discovery may be first plant cell surface molecule that halts cell proliferation
11. Discovery may help in war against fire ants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... , ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel ... 1pm EDT to learn about two common imaging methods in NAFLD/NASH to aid with ... common diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be ...
(Date:8/9/2019)... ... August 09, 2019 , ... With a demand in healthcare to lower unneeded ... visit urgent care centers (UCC) in the coming years, according to a new report ... for Urgent Care Centers , is a detailed look at the current state of ...
(Date:8/6/2019)... ... August 06, 2019 , ... The demand ... plant-based food in particular quickly entered the limelight – meat alternatives. Yet, to ... thermogelling and emulsifying ingredient such as methyl cellulose. This ingredient is highly synthetic. ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... ... add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. ... continually expanding library of more than 20 million articles, sourced from more than ...
(Date:6/11/2019)... ... 2019 , ... Veterinary Regenerative Medicine company, VetStem Biopharma ... that their GMP facility for cell production is now approved by the California ... an important milestone for VetStem as it expands into contract cell manufacturing services. ...
(Date:6/6/2019)... ... 05, 2019 , ... WCCT Global, Inc ., a full-service early phase ... they will be receiving 3 awards at the 2019 CRO Leadership Awards, to be ... the categories of overall Quality and Compatibility (Access to desired markets, cultural fit, timely ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... providing proprietary interest to our methodology, processes, and diagnostic techniques. The patent ... extends Somnology’s IP rights including our proprietary sleep scoring methodology. The approval ...
Breaking Biology Technology:
Cached News: